| abstract |
The invention discloses an application of schisandrin B in the preparation of a drug for treating diabetic complications; wherein, schisandrin B reduces the action mechanism of chronic inflammation by targeting and inhibiting the production of myeloid differentiation factor 88 (MyD88), so as to treat diabetic complications Effect. The Schizandrin B is preferably administered orally (for the preparation of powders, tablets, pills, oral liquids and capsules); Schisandrin B can effectively alleviate the occurrence and development of diabetic cardiomyopathy and diabetic nephropathy, and can be used for the treatment of diabetic complications. The main ingredient in the medicine. |